Biblio Discovery — Demo Discovery Service

91 results for "Burisch, Johan"

Showing 41–60 · 0.31 seconds · RSS

  1. Journal Article Full text

    Risk Factors for Developing Inflammatory Bowel Disease Within and Across Families with a Family History of IBD

    Torres, Joana; Gomes, Catarina; Jensen, Camilla B et al.

    J Crohns Colitis · 2022 · English · PubMed Central

    INTRODUCTION: A family history of inflammatory bowel disease [IBD] is the strongest risk factor for disease. However, some first-degree relatives (FDRs) will develop disease, while others will not. METHODS: Using the nationwide Danish National Patient Register, we examined risk factors in families…

  2. Journal Article Full text

    The Costs of Home Monitoring by Telemedicine vs Standard Care for Inflammatory Bowel Diseases—A Danish Register-Based, 5-Year Follow-up Study

    Al-Sheikh, Marwah; Ankersen, Dorit Vedel; Olsen, Jens et al.

    J Crohns Colitis · 2024 · English · PubMed Central

    BACKGROUND AND AIMS: There are few studies on the cost-effectiveness of telemedicine for inflammatory bowel diseases. We assessed the long-term cost-effectiveness of a telemedicine solution compared to standard care (sCare), as well as its efficacy according to patient-reported outcomes (PROs)…

  3. Journal Article Full text

    Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study

    Misra, Ravi; Limdi, Jimmy; Cooney, Rachel et al.

    World J Gastroenterol · 2019 · English · PubMed Central

    BACKGROUND: The current epidemiology of inflammatory bowel disease (IBD) in the multi-ethnic United Kingdom is unknown. The last incidence study in the United Kingdom was carried out over 20 years ago. AIM: To describe the incidence and phenotype of IBD and distribution within ethnic groups…

  4. Journal Article Full text

    Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study

    Podmore, Bélène; Beier, Dominik; Burisch, Johan et al.

    United European Gastroenterol J · 2023 · English · PubMed Central

    BACKGROUND: Patients with inflammatory bowel disease are at increased risk of colorectal and extra‐intestinal cancer. However, the overall cancer risk in patients with Crohn's disease (CD) with perianal fistulas (PF) (CPF) and those with CD without PF (non‐PF CD) is unclear. OBJECTIVE: To describe…

  5. Journal Article Full text

    Musculoskeletal Symptoms and Clinical Findings in Bio-naïve Patients with Inflammatory Bowel Disease Prior to Biological Treatment Initiation: A Prospective Cohort Study

    Vladimirova, Nora; Zhao, Mirabella; Ørnbjerg, Lykke Midtbøll et al.

    Dig Dis Sci · 2025 · English · PubMed Central

    BACKGROUND: Musculoskeletal involvement in inflammatory bowel disease (IBD) patients contributes to poorer outcomes and reduced quality of life (QoL). We aimed to describe the prevalence and distribution of peripheral and axial musculoskeletal symptoms and clinical findings in patients with IBD…

  6. Journal Article Full text

    Stopping 5-Aminosalicylate Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes

    Ungaro, Ryan C.; Limketkai, Berkeley N.; Jensen, Camilla Bjørn et al.

    Clin Gastroenterol Hepatol · 2019 · English · PubMed Central

    BACKGROUND & AIMS: Little is known about the effects of discontinuing 5-aminosalycilates (5-ASA) therapy for patients with Crohn’s disease (CD) who initiate therapy with an anti-tumor necrosis factor (anti-TNF) agent. We analyzed data from 2 national population cohorts to compare outcomes of…

  7. Journal Article Full text

    MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT)

    Frimor, Camilla; Steenholdt, Casper; Widigson, Ella Signe Kassandra et al.

    BMJ Open Gastroenterol · 2025 · English · PubMed Central

    INTRODUCTION: Biologic therapies, such as vedolizumab (VDZ) and ustekinumab (UST), offer effective treatment options for inflammatory bowel disease. In spite of limited evidence, it is common practice to escalate the dosing regimen if clinical symptoms or biomarkers give suspicion of loss of…

  8. Journal Article Full text

    Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study

    Thomsen, Sandra Bohn; Allin, Kristine Højgaard; Burisch, Johan et al.

    United European Gastroenterol J · 2019 · English · PubMed Central

    BACKGROUND: Thiopurine and allopurinol in combination are associated with clinical remission in inflammatory bowel diseases but their influence on subsequent outcomes is unclear. We compared outcomes during exposure to both thiopurines and allopurinol versus thiopurines alone. METHODS: We…

  9. Journal Article Full text

    Current challenges and future needs of clinical and endoscopic training in gastroenterology: a European survey

    Maida, Marcello; Alrubaiy, Laith; Bokun, Tomislav et al.

    Endosc Int Open · 2020 · English · PubMed Central

    Background and study aims A universal European training program in gastroenterology and hepatology is currently not available. The European Board of Gastroenterology and Hepatology (EBGH) has produced guidance regarding expected competencies for European gastroenterology trainees but it is unclear…

  10. Journal Article Full text

    Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study

    Attauabi, Mohamed; Seidelin, Jakob Benedict; Felding, Oluf Krautwald et al.

    J Autoimmun · 2021 · English · PubMed Central

    BACKGROUND: Limited data exist regarding the disease course of coronavirus disease 2019 (COVID-19) and its relationship with immunosuppressants among patients with immune-mediated inflammatory diseases (IMIDs). Therefore, this study aims to investigate the association between COVID-19, frequent…

  11. Journal Article Full text

    The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

    Amiot, Aurelien; Rahier, Jean-Francois; Baert, Filip et al.

    J Crohns Colitis · 2022 · English · PubMed Central

    BACKGROUND AND AIMS: There are concerns regarding the potential impact of the COVID-19 outbreak on patients with inflammatory bowel disease [IBD]. We report on the impact of the COVID-19 outbreak in a European prospective cohort study of patients with IBD PATIENTS AND METHODS: We prospectively…

  12. Journal Article Full text

    Fear of COVID-19 Among Patients with Inflammatory Bowel Disease as Compared to Patients with Other Gastrointestinal Conditions

    Lo, Bobby; Barreiro-de Acosta, Manuel; Bernstein, Charles N. et al.

    Turk J Gastroenterol · 2022 · English · PubMed Central

    BACKGROUND: Although several studies have reported the impact of fears relating to coronavirus-19 on several chronic illnesses, there are few studies focused on gastrointestinal conditions. Therefore, the aim of this study was to compare the fear of coronavirus-19 in patients with inflammatory…

  13. Journal Article Full text

    Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort

    Berbisá, Marjun á Fríðirksmørk; Nielsen, Kári Rubek; Ingham, Anna Cäcilia et al.

    Inflamm Bowel Dis · 2022 · English · PubMed Central

    BACKGROUND: The Faroe Islands has the world’s highest incidence of inflammatory bowel disease (IBD). Epidemiological studies have characterized this unique cohort and a decreased risk of developing IBD with emigration. Therefore, this well-characterized Faroese IBD cohort gives the opportunity to…

  14. Journal Article Full text

    Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives

    Tran, Florian; Schirmer, Jan Henrik; Ratjen, Ilka et al.

    Front Immunol · 2021 · English · PubMed Central

    Chronic inflammatory diseases (CID) are emerging disorders which do not only affect specific organs with respective clinical symptoms but can also affect various aspects of life, such as emotional distress, anxiety, fatigue and quality of life. These facets of chronic disease are often not…

  15. Journal Article Full text

    Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort

    Ovesen, Pernille Dige; Attauabi, Mohamed; Ilvemark, Johan F K F et al.

    BMJ Open Gastroenterol · 2024 · English · PubMed Central

    BACKGROUND AND OBJECTIVE: The influence of concomitant prednisolone on clinical outcomes and safety in infliximab-treated ulcerative colitis (UC) patients is unknown. DESIGN, SETTING, PARTICIPANTS AND OUTCOME MEASURES: A retrospective cohort study was performed, including 147 UC patients treated…

  16. Journal Article Full text

    A Low Dietary Quality Index in a Newly Diagnosed Inflammatory Bowel Disease Cohort: Results from a Case—Control Study

    Misra, Ravi; Dyall, Lovesh; Kyle, Janet et al.

    Nutrients · 2025 · English · PubMed Central

    Background: Epidemiological evidence suggests a link between the risk of IBD and diet. Macro- and micro- nutrient intake, diet quality and dietary patterns may play a pivotal role in disease pathogenesis. We aimed to study the dietary intake of newly diagnosed IBD patients compared to non-IBD…

  17. Journal Article Full text

    Clinical Trial: Evaluating a Single 1600 mg Tablet Regimen of 5‐Aminosalicylate for Ulcerative Colitis—The EASI Trial

    Nordestgaard, Rie Louise Møller; Lo, Bobby; Bergstrøm, Rosalina et al.

    Aliment Pharmacol Ther · 2025 · English · PubMed Central

    BACKGROUND: 5‐Aminosalicylate (5‐ASA) is recommended for the treatment of mild‐to‐moderate ulcerative colitis (UC). However, adherence may be low; poor adherence is associated with an increased risk for flares. AIM: To investigate whether a regimen of a single 1600 mg tablet of 5‐ASA improves…

  18. Journal Article Full text

    The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey

    Madsen, Gorm Roager; Wilkens, Rune; Boysen, Trine et al.

    Aliment Pharmacol Ther · 2022 · English · PubMed Central

    BACKGROUND: Intestinal ultrasound (IUS) is a non‐invasive modality for monitoring disease activity in inflammatory bowel diseases (IBD). IUS training currently lacks well‐defined standards and international consensus on competency criteria. Aim: To achieve international consensus on what…

  19. Journal Article Full text

    Exploring the Impact of Covid-19-Related Perceptions on Psychological Distress and Quality of Life in an International Gastrointestinal Cohort Over Time Guided by the Common Sense Model

    Knowles, Simon R.; Möller, Stephan P.; Stengel, Andreas et al.

    J Clin Psychol Med Settings · 2023 · English · PubMed Central

    The aim of this longitudinal study was to examine changes in COVID-19 and illness-related perceptions, gastrointestinal symptoms, coping, catastrophising, psychological distress, and QoL during the COVID-19 pandemic. A total of 831 adults with a gastrointestinal condition completed an online…